Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases “in real life situation”-Reference-Cited by-同舟云学术

Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases “in real life situation”

Published:2022-08-12 Issue:32 Volume:101 Page:e30025
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Zougmoré Honoré Tegwendé,Cadranel Jean François David,Fantognon Gildas,Azzi Badia,Smadhi Ryad,Ngele Efole Jean René,Mrabti Samir,Heng Ratmony,Ntsama Marie Adrienne,Medmoun Mourad,Kazerouni Firouzeh,Le Magoarou Tristan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).;Poynard;BMC Gastroenterol,2010

2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.;J Hepatol,2011

3. Practices of liver biopsy in France: result of a prospective nationwide survey.;Cadranel;Hepatology,2000

4. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis.;J Hepatol,2021

5. Ultrasonographic assessment of liver fibrosis with computer-assisted analysis of liver surface irregularities.;Huet;Diagn Interv Imaging,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of hepatic steatosis and fibrosis in Turner syndrome: A prospective case–control study;Liver International;2024-02-23

2. Frequency of fibrosis in patients with incidentally detected hepatosteatosis;Revista da Associação Médica Brasileira;2024

3. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges;The Journal of Clinical Endocrinology & Metabolism;2023-02-07